top of page
Anti-CD10 (clone QR021)

Anti-CD10 (clone QR021)

CD10 (Clone QR021) – Optimal Staining in NordiQC Run 66, 2022

CD10, also known as CALLA (common acute lymphoblastic leukemia antigen), neprilysin, and neutral endopeptidase, is a zinc-dependent metalloprotease that degrades various small secretory peptides. It plays a functional role in:
Regulating cellular responses to peptide substrates
Proteolytic processes in the kidneys
Cardiovascular system regulation
Immune response modulation
Cell proliferation
Fetal development

CD10 was first identified as a tumor-specific antigen in acute lymphoblastic leukemia (ALL) and is a surface ectoenzyme widely expressed in various cell types.

CD10 Expression in Normal Cells

CD10 is present on the surface of:
Hematopoietic stem cells and myelopoietic cells (including neutrophils)
Follicular center B cells
A subset of mature B lymphocytes
A parafollicular subset of T lymphocytes

Additionally, CD10 is expressed in non-lymphoid cells, such as:
Glomerular epithelial cells and proximal tubule brush border (kidney)
Biliary ductal cells (liver)
Alveolar epithelial cells (lungs)
Myoepithelial cells of the breast, sweat glands, and salivary glands
Glandular epithelial cells of the prostate
Trophoblast cells (placenta)
Endometrial stromal cells
Some endothelial cells

CD10 Expression in Tumors

CD10 is highly expressed in:
B-cell acute lymphoblastic leukemia (B-ALL)
Follicular lymphoma (FL)
Burkitt lymphoma (BL)

Diagnostic Applications of CD10

CD10 is a useful marker for classifying:
B-cell leukemias and lymphomas
Hepatocellular and renal cell carcinomas
Metaplastic breast carcinoma (useful for prognosis in breast cancer)
Mesenchymal tumors of the uterus, such as endometrial stromal sarcoma

CD10 is an important diagnostic and prognostic marker, widely used in hematopathology and solid tumor oncology.

  • Literature

    [1] Mishra D et al. (2016). Mol Biol Int. 2016:4328697.

    [2] Nalivaeva NN et al. (2020). Mech Ageing Dev. 192:111363.

  • Advantage of QUARTETT Antibodies

    ADVANTAGES OF RECOMBINANT RABBIT MONOCLONAL ANTIBODIES

    Recombinant rabbit monoclonal antibodies—referred to as Q-clones—combine the best properties of both murine monoclonal and rabbit polyclonal antibodies, offering a broader diagnostic potential.

    Key Advantages of Our Next-Generation Recombinant Rabbit Monoclonal Antibodies

    High Affinity due to rabbit origin, enabling greater sensitivity in assays—these antibodies bind strongly to antigens and maintain their bond even under challenging conditions, unlike low-affinity antibodies.

    Superior Specificity with reduced risk of cross-reactivity, thanks to their monoclonal nature.

    Expanded Antigen Recognition—better recognition of diverse antigens and epitopes.

    Target Epitopes Poorly Recognized by Mouse-Derived Antibodies, improving detection in certain applications.

    Enhanced Response to Small-Sized Epitopes, making them ideal for challenging targets.

    Significantly Improved Recognition of Murine Antigens, broadening their usability in research and diagnostics.

    Lower Background Staining, ensuring cleaner and more reliable results.

    Recombinant vs. Hybridoma Antibody Generation

    Exceptional Consistency, Specificity, and Sensitivity—eliminating risks of gene loss, mutations, or cell line drift.

    Reliable and Controlled Production—generated from a unique gene set, ensuring stable antibody performance.

    Batch-to-Batch Consistency, guaranteeing reproducible results and long-term product availability.

    Efficient In Vitro High-Throughput Production, allowing easy standardization and scalable antibody expression for any application.

    Recombinant rabbit monoclonal antibodies represent the future of immunohistochemistry, offering unmatched reliability and precision in diagnostic and research settings.

    bottom of page